Breaking News
March 21, 2018 - Dermira’s Two Phase 3 Trials Evaluating Olumacostat Glasaretil in Patients with Acne Vulgaris Did Not Meet Co-Primary Endpoints
March 21, 2018 - ‘Oh, It Was Nothing’
March 21, 2018 - Herbal drug kratom linked to salmonella illnesses, CDC says
March 21, 2018 - New optical point-of-care device could enhance screening for thyroid nodules
March 21, 2018 - FDA Expands Approval of Adcetris (brentuximab vedotin) for First-Line Treatment of Stage III or IV Classical Hodgkin Lymphoma in Combination with Chemotherapy
March 21, 2018 - Eosinophilic Esophagitis: Late Manifestation of Allergic March
March 21, 2018 - Signaling pathway involving the Golgi apparatus identified in cells with Huntington’s disease
March 21, 2018 - Quintupling inhaled steroid doses may not benefit children with asthma
March 21, 2018 - Study shows clear connection between cardiovascular fitness in middle age and dementia risk
March 21, 2018 - Premature babies have higher risks of health complications in Bangladesh
March 21, 2018 - Child’s temperament and parenting influence weight gain in babies
March 21, 2018 - Researchers find the heart to be capable of arrhythmia termination after local gene therapy
March 21, 2018 - Inhealthcare to provide digital infrastructure for NHS to help protect people from falls
March 21, 2018 - Flu Season Finally Slowing Down
March 21, 2018 - Mixed Results for Shorter DAPT in ACS Patients
March 21, 2018 - Scientists discover fish scale-derived collagen effective for healing wounds
March 21, 2018 - Genomics England announces new partnership to improve efficiency of next-generation sequencing analysis
March 21, 2018 - Adjuvant AC chemotherapy found to be effective in treating HRD-positive breast cancer patients
March 21, 2018 - Researchers identify new treatment targets for lung diseases using big data
March 21, 2018 - Kids see more women in science than five decades ago
March 21, 2018 - Research shows link between chronic fatigue syndrome and lower thyroid hormone levels
March 21, 2018 - Alzheimer’s disease on the rise
March 21, 2018 - Two Agents Equal as Pretreatment for Adrenal Tumor Surgery
March 21, 2018 - ‘Icebreaker’ protein opens genome for T cell development, researchers find
March 21, 2018 - Women in medicine shout #Metoo about sexual harassment at work
March 21, 2018 - Mother’s pre-pregnancy waist size may be linked to child’s autism risk
March 21, 2018 - Second hand marijuana smoke can cause serious damage
March 21, 2018 - International study shows benefits of using MRI at the start of prostate cancer diagnosis
March 20, 2018 - Santhera Reports Outcome of Exploratory Trial with Idebenone in PPMS Conducted at the NIH
March 20, 2018 - ECG Patch Ups At-Home Afib Diagnosis in mSToPS Trial
March 20, 2018 - ROS-scavenging nanozymes for anti-inflammation therapeutics
March 20, 2018 - Genomics England announces appointment of global genomics pioneer as first CEO
March 20, 2018 - Test flight at German Aerospace Center in Cologne demonstrates functionality of deficopter
March 20, 2018 - Music therapy helps treat combat-related psychological injuries in military personnel
March 20, 2018 - Innovative psychotherapeutic treatment protocol for obsessive-compulsive disorders
March 20, 2018 - Weight loss after lap-band surgery alleviates arthritic knee pain
March 20, 2018 - New diabetes drug may help obese people shed body weight
March 20, 2018 - Novel Peanut OIT a Winner in Phase III Trial
March 20, 2018 - Can gene therapy be harnessed to fight the AIDS virus?
March 20, 2018 - Education and academic achievement can lessen effects of child abuse, neglect
March 20, 2018 - Researchers develop new algorithm to make CPR more effective
March 20, 2018 - Diabetes medication reduces chance of late miscarriage, premature birth among women with PCOS
March 20, 2018 - SSRIs may be more effective option for treating anxious youth, UC research shows
March 20, 2018 - Antibiotics could benefit women suffering from chronic bladder pain
March 20, 2018 - Health Highlights: March 16, 2018
March 20, 2018 - Interventional Radiology Has a Problem of ‘Unseen’ Value
March 20, 2018 - Antibodies show effectiveness for HIV prevention and promise for treatment and cure
March 20, 2018 - New 3-D-printed technology will improve radiology training
March 20, 2018 - New study identifies key role for particular gene in 16p11.2 deletion syndrome
March 20, 2018 - Red and processed meat increase the risk of liver disease
March 20, 2018 - 50% of Australians do not brush teeth twice a day
March 20, 2018 - American Gene Technologies receives second immuno-oncology patent
March 20, 2018 - Study finds no link between long-term violent video game play and adult aggression
March 20, 2018 - Weight loss surgery widely underutilized among young patients with severe obesity
March 20, 2018 - Scientists uncover new answers to cell aging in children with rare, fatal disease
March 20, 2018 - The Pistoia Alliance Calls for Greater Life Sciences Collaboration to Build the ‘Lab of the Future’
March 20, 2018 - Morning Break: Psychopathic Thought; Americans Flout Zzz’s; Farm to Pharma
March 20, 2018 - Perceptions of old age change as we age
March 20, 2018 - New standards for public involvement in research launched across the UK
March 20, 2018 - Whole Genome Sequencing used as diagnostic solution for TB
March 20, 2018 - Researchers show how two cancer genes work together to trigger leukemia
March 20, 2018 - Scientists discover basic molecular mechanism that helps understand how ALS works
March 20, 2018 - Multi-center study to evaluate promising new intervention for upper limb dysfunction after SCI
March 20, 2018 - Researchers develop technology to program DNA for delivering cancer drugs
March 20, 2018 - Northwestern scientists bring precision medicine to rheumatoid arthritis
March 20, 2018 - Research suggests possible link between heading a soccer ball and brain imbalance
March 20, 2018 - Robocall increases diabetic retinopathy screening rates among poor minorities
March 20, 2018 - INSYS Therapeutics Initiates Phase 3 Clinical Trial of Cannabidiol (CBD) Oral Solution for Treatment of Infantile Spasms
March 20, 2018 - Little Talk Between Docs and Patients Pre-PSA Screen
March 20, 2018 - Women GPs bring remote care to rural Pakistan
March 20, 2018 - Adults skipping vaccines may miss out on effective new shingles shot
March 20, 2018 - Suppressing emotions appears to reduce negative memories
March 20, 2018 - Epidural stimulation can safely, effectively normalize blood pressure in patients with SCI
March 20, 2018 - ‘Fast track’ project shows promising results in cancer whole genome analyses
March 20, 2018 - Advanced insulin pump system can also manage type 1 diabetes in children, study shows
March 20, 2018 - Flu risk less on flights if in a window seat finds study
March 20, 2018 - Sarepta Therapeutics Announces Plan to Submit a New Drug Application (NDA) for Accelerated Approval of Golodirsen (SRP-4053) in Patients with Duchenne Muscular Dystrophy (DMD) Amenable to Skipping Exon 53
March 20, 2018 - Post-Transplant Fatty Liver Disease on the Rise
March 20, 2018 - New mutation linked to ovarian cancer can be passed down through dad
March 20, 2018 - Alex’s experiences of living with rare genetic disease
Amber-Tinted Glasses Might Get You More Sleep

Amber-Tinted Glasses Might Get You More Sleep

image_pdfDownload PDFimage_print

TUESDAY, Dec. 26, 2017 — For the tech-obsessed who use their smartphones, laptops and tablets right before bedtime, a small new study suggests that inexpensive amber-tinted glasses might guarantee sound slumber.

The glasses block the blue-wavelength light emitted from many hi-tech devices. That light suppresses the brain’s production of melatonin, a hormone that regulates sleep and wake cycles.

But in the study, researchers found that adults diagnosed with insomnia got about 30 minutes more sleep when wearing wrap-around amber lenses for two hours before bedtime.

“We expect that blue-light exposure before bedtime might contribute to sleep difficulties or exacerbate sleep problems in individuals who already experience difficulties, so we were not surprised there was an improvement in sleep quality,” said study author Ari Shechter. He’s an assistant professor of medical sciences at Columbia University Medical Center in New York City.

“These kinds of glasses are very widely available, probably for $5 to $10, although more expensive options might be available for different styles,” added Shechter, who doesn’t have a financial stake in the findings.

Insomnia symptoms such as difficulty falling or staying asleep, frequent awakening or disturbed sleep occur in as many as one-third to one-half of adults, according to background information in the study. In addition, an estimated 90 percent of Americans use light-emitting electronic devices — such as tablets, smartphones and computers — in the hour before bedtime, despite the sleep-inhibiting effects of this blue-light exposure.

In the new study, 14 adults with chronic insomnia wore wrap-around, amber-tinted glasses or clear placebo glasses for two hours before bedtime for seven consecutive nights. Four weeks later, participants repeated the process with the other set of glasses.

In addition to getting about a half-hour more sleep on nights after wearing the amber lenses, participants also reported better-quality sleep and an overall reduction in their insomnia symptoms.

A slight reduction in the time it took amber lenses-wearing participants to fall asleep was noted, though it wasn’t statistically significant. “It is possible the intervention would be more effective in speeding up time to fall asleep in individuals who have difficulty falling asleep as their chief sleep complaint,” Shechter said.

Many smartphone screens can be adjusted to emit amber instead of blue light, which would be another step toward reducing insomnia symptoms in those affected. Blue-wavelength light is also emitted from many light bulbs and LED light sources increasingly being used in homes because of their energy efficiency and cost-effectiveness, he noted.

“Now more than ever, we are exposing ourselves to high amounts of blue-wavelength light before bedtime, which may contribute to or exacerbate sleep problems,” Shechter said.

“We believe this to be an important and timely study, as it describes a safe, affordable and easily implemented intervention for insomnia,” he added.

“Avoiding exposure to light from light-emitting devices before sleep would be the best approach, but using other techniques to block the blue light can help if the devices will continue to be used,” Shechter suggested.

Dr. Raman Malhotra is a spokesperson for the American Academy of Sleep Medicine and wasn’t involved in the research. He agreed with Shechter that the research should be replicated in larger numbers of patients with insomnia, possibly over longer periods of time.

But Malhotra said some doctors are already recommending patients with insomnia wear amber-tinted glasses before bedtime, reasoning there’s little to lose.

“I look at cost or risk compared to possible benefit, and in this case I feel cost and harm are minimal compared to benefits in patients’ sleep,” said Malhotra, an associate professor of neurology at the Washington University Sleep Medicine Center in St. Louis.

“Very large portions of the population have trouble sleeping because of the light coming from their devices, and this is a very reasonable thing to use,” he added.

The study is scheduled for publication in the January issue of the Journal of Psychiatric Research.

More information

The National Sleep Foundation offers more tips for sounder sleep.

© 2017 HealthDay. All rights reserved.

Posted: December 2017

Tagged with:

About author

Related Articles